Rhode Island Healthcare
Compliance Guide

Rhode Island presents a moderately favorable regulatory environment for healthcare companies, particularly those leveraging telehealth. The state has actively embraced telehealth expansion, especially following the COVID-19 pandemic, codifying many temporary flexibilities into permanent law. This commitment is reflected in its robust reimbursement parity laws and broad definitions of telehealth modalities. Key regulatory bodies include the Rhode Island Department of Health (RIDOH), which oversees licensing and public health, and various professional licensing boards such as the Board of Medical Licensure and Discipline, the Board of Examiners in Dentistry, and the Board of Nurse Registration and Nursing Education. These boards are responsible for enforcing scope of practice, prescribing rules, and professional conduct. The general business climate is supportive of healthcare innovation, though companies must navigate a well-established regulatory framework designed to protect patient safety and prevent corporate interference in medical decisions. Recent legislative actions have focused on solidifying telehealth access, addressing behavioral health needs, and refining controlled substance prescribing regulations. While not as restrictive as some states regarding the Corporate Practice of Medicine, Rhode Island maintains clear distinctions between professional and corporate entities. Companies expanding into Rhode Island should anticipate a comprehensive but navigable regulatory landscape, requiring diligent adherence to licensing, operational, and structural compliance to ensure successful and lawful operations.

Rhode Island maintains a Corporate Practice of Medicine (CPOM) doctrine, though it is not as stringently enforced or explicitly codified as in some other states like California or Texas. The legal basis for Rhode Island's CPOM largely stems from common law principles, statutory provisions governing professional licensure, and the implied prohibition against unlicensed entities practicing medicine. The primary concern is that a lay entity should not control the professional judgment of a licensed practitioner.

Legal Basis and Enforcement: While there isn't a single overarching CPOM statute, the Rhode Island General Laws, specifically Title 5 (Businesses and Professions), implicitly uphold the doctrine by requiring that the practice of medicine, dentistry, nursing, etc., be conducted by licensed individuals or entities specifically authorized to do so. For example, R.I. Gen. Laws § 5-37-2 defines the practice of medicine, and subsequent sections detail licensing requirements. The Board of Medical Licensure and Discipline (BMLD) is responsible for enforcing these provisions, ensuring that medical decisions remain solely within the purview of licensed physicians. Enforcement typically arises from complaints regarding unlicensed practice, fee-splitting, or undue influence over clinical decisions.

Permitted Ownership Structures and Restrictions: Rhode Island permits the formation of professional service corporations (PSCs) or professional limited liability companies (PLLCs) for licensed professionals. R.I. Gen. Laws § 7-5.1-1 et seq. (Professional Service Corporations) and § 7-16-1 et seq. (Rhode Island Limited Liability Company Act) allow licensed individuals to form these entities to render professional services. The key restriction is that only licensed professionals in that specific field (e.g., physicians for a medical practice, dentists for a dental practice) can be shareholders, members, or officers who control the professional decisions of the entity.

Non-Physician Ownership: Generally, non-physicians cannot directly own a medical practice that employs physicians or dictates medical decisions. However, non-physicians can own entities that provide administrative, management, or technical services to professional medical practices, often structured as a Management Services Organization (MSO) model. This model must be carefully constructed to avoid CPOM violations, ensuring the MSO does not control clinical decisions, employ licensed practitioners, or engage in fee-splitting that could be construed as profiting from the practice of medicine itself.

Impact on Telehealth, Medspas, Dental Practices, and Wellness Clinics:

• Telehealth Companies: Telehealth platforms operating in Rhode Island must ensure that the professional medical entity employing or contracting with licensed providers is physician-owned or owned by licensed professionals in the relevant field (e.g., NPs for certain services). Non-clinical aspects like technology, marketing, and billing can be managed by a separate, lay-owned MSO. The MSO cannot direct or interfere with the physician's independent medical judgment.
• Medspas: Medspas offering medical procedures (e.g., injectables, laser treatments) must operate under the direct supervision and ownership structure compliant with medical practice laws. The medical director must be a licensed physician, and the entity performing the medical services should ideally be a professional corporation owned by licensed medical professionals. Non-medical services (e.g., facials, massages) can be offered by a lay-owned entity, but clear separation and avoidance of commingling are crucial.
• Dental Practices: Similar to medical practices, dental practices must be owned by licensed dentists. R.I. Gen. Laws § 5-31.1-1 et seq. governs the practice of dentistry, and the Board of Examiners in Dentistry enforces these provisions. Lay ownership of dental practices is prohibited.
• Wellness Clinics: The CPOM implications for wellness clinics depend on the nature of services offered. If services involve diagnosis, treatment, or prescribing (e.g., IV therapy, hormone therapy), they fall under the medical practice rules and require professional ownership. If services are purely advisory, educational, or non-medical (e.g., personal training, nutritional coaching without medical claims), lay ownership is generally permissible.

In all cases, the critical distinction is who holds clinical decision-making authority and who ultimately profits from the professional services rendered. Any structure that allows a non-licensed entity to control clinical judgment or to directly profit from the provision of medical services by licensed professionals is at risk of violating Rhode Island's CPOM principles.

Rhode Island has established a comprehensive framework for telehealth, largely codified in R.I. Gen. Laws § 27-20-1.1 and regulations promulgated by the Rhode Island Department of Health (RIDOH) and professional licensing boards. The state generally promotes telehealth as an integral part of healthcare delivery.

Establishment of Provider-Patient Relationship: Rhode Island law explicitly permits the establishment of a bona fide provider-patient relationship via telehealth. R.I. Gen. Laws § 27-20-1.1(a)(2) defines 'telehealth' as the use of electronic information and communication technologies to deliver health care services, including diagnosis, consultation, treatment, transfer of medical data, and education. The law does not mandate a prior in-person visit to establish this relationship, allowing for initial encounters to occur remotely. However, the standard of care for a telehealth encounter must be equivalent to that of an in-person encounter, meaning the provider must gather sufficient information to make an informed clinical judgment.

Permitted Modalities: Rhode Island's telehealth laws are inclusive regarding modalities:

• Video (Synchronous Audio-Visual): This is the preferred and most commonly accepted modality, explicitly covered by the definition. It allows for real-time interaction and visual assessment.
• Audio-Only (Synchronous Audio): R.I. Gen. Laws § 27-20-1.1(a)(2) includes 'audio-only telephone communication' as a permissible telehealth modality, particularly when audio-visual is not available or appropriate, or when used for behavioral health services. This is a significant flexibility compared to some other states.
• Asynchronous (Store-and-Forward): The definition of telehealth also includes 'store-and-forward technologies,' which allow for the transmission of recorded health information (e.g., images, pre-recorded video, data) to a practitioner for review at a later time. This is permissible, provided it meets the standard of care.
• Remote Patient Monitoring (RPM): While not explicitly detailed as a separate modality in the core telehealth definition, RPM falls under the broader scope of 'electronic information and communication technologies' used for health care services and is generally permitted and reimbursed.

Telehealth Registration Requirements: Rhode Island does not have a specific, separate 'telehealth registration' requirement for providers who are already licensed in the state. However, out-of-state providers seeking to offer telehealth services to Rhode Island residents must be fully licensed by the appropriate Rhode Island professional board (e.g., Board of Medical Licensure and Discipline, Board of Nurse Registration and Nursing Education). Participation in interstate compacts like the Interstate Medical Licensure Compact (IMLC) or the Nurse Licensure Compact (NLC) facilitates this for eligible professionals. For those not part of a compact, full Rhode Island licensure is mandatory.

Informed Consent Requirements: Prior to initiating telehealth services, informed consent is required. R.I. Gen. Laws § 27-20-1.1(b)(3) mandates that the health care provider obtain informed consent from the patient, or the patient's legal guardian, for the use of telehealth services. This consent should include information about the nature of telehealth, potential risks and benefits, privacy and security measures, and the patient's right to withdraw consent. The consent must be documented in the patient's medical record.

Geographic Restrictions: There are generally no geographic restrictions within Rhode Island for telehealth services, meaning a provider licensed in Rhode Island can provide telehealth services to a patient located anywhere within the state. However, the provider must be physically located in a state where they are licensed to practice when providing services to a Rhode Island patient. For out-of-state providers, as noted, Rhode Island licensure is required to treat Rhode Island patients, regardless of the patient's specific location within the state.

Rhode Island's prescribing rules for telehealth largely align with in-person prescribing standards, with specific considerations for controlled substances. The Board of Medical Licensure and Discipline (BMLD) and the Department of Health (RIDOH) oversee these regulations.

Controlled Substance Prescribing via Telehealth: Rhode Island generally permits the prescribing of controlled substances via telehealth, provided a legitimate patient-provider relationship has been established and the prescribing is for a legitimate medical purpose in the usual course of professional practice. This aligns with federal DEA regulations, which, following the COVID-19 Public Health Emergency (PHE), have maintained flexibilities allowing for prescribing of controlled substances without an initial in-person exam under certain circumstances. However, the DEA's proposed rules for post-PHE prescribing could reintroduce stricter requirements, so providers must monitor federal developments closely. Rhode Island's state law, R.I. Gen. Laws § 21-28-5.01 (Uniform Controlled Substances Act), does not explicitly prohibit telehealth prescribing of controlled substances but emphasizes the need for a proper medical evaluation.

Which Schedules Can Be Prescribed: All schedules of controlled substances (Schedules II-V) can potentially be prescribed via telehealth in Rhode Island, provided the prescribing practitioner adheres to the standard of care and all other state and federal requirements. There are no blanket prohibitions on specific schedules for telehealth at the state level, but clinical appropriateness and the establishment of a valid patient-provider relationship are paramount.

Specific DEA Requirements: Providers prescribing controlled substances via telehealth must hold a valid DEA registration. While the DEA's temporary flexibilities allowed for prescribing without an initial in-person visit during the PHE, the long-term rules are still under consideration. Providers should assume that, absent further federal action, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation or a qualifying telemedicine encounter (as defined by the DEA) for prescribing controlled substances. The current DEA position allows for telehealth prescribing of controlled substances without an in-person exam if the practitioner has previously conducted an in-person medical evaluation or if the prescribing is done under a qualifying telemedicine referral. Practitioners should consult the latest DEA guidance.

PDMP Checking Required: Yes, Rhode Island mandates the use of its Prescription Drug Monitoring Program (PDMP). R.I. Gen. Laws § 21-28-5.04 requires practitioners to check the PDMP database prior to prescribing or dispensing an opioid or benzodiazepine to a patient for the first time, and at least every 90 days thereafter for ongoing prescriptions. This requirement applies equally to telehealth encounters. Failure to check the PDMP can result in disciplinary action.

Quantity or Refill Limitations: Rhode Island has specific limitations on opioid prescriptions. For acute pain, R.I. Gen. Laws § 21-28-5.04(a)(1) limits the initial prescription of an opioid to a seven-day supply for adults and a five-day supply for minors. Subsequent prescriptions require a re-evaluation. There are exceptions for chronic pain, cancer treatment, palliative care, and medication-assisted treatment (MAT). These limitations apply to both in-person and telehealth prescribing. Other controlled substances may have quantity or refill limitations based on clinical guidelines but not typically by explicit state statute for all schedules.

Special Rules for Specific Drug Classes:

• GLP-1s (e.g., Ozempic, Wegovy): While not controlled substances, prescribing GLP-1 agonists via telehealth requires a thorough medical evaluation, including patient history, physical assessment (which may be conducted remotely if clinically appropriate), and monitoring. Prescribing for off-label use (e.g., weight loss for non-diabetic patients) must be done with clear medical justification and informed consent, adhering to the standard of care.
• Testosterone (Controlled Substance, Schedule III): Prescribing testosterone via telehealth is permitted but requires careful clinical assessment, including lab work and a documented medical need for hormone replacement therapy. Adherence to DEA and state controlled substance regulations is critical.
• Stimulants (Controlled Substances, Schedule II): Prescribing stimulants (e.g., Adderall, Ritalin) for conditions like ADHD via telehealth is permissible but subject to heightened scrutiny. A comprehensive psychiatric evaluation, including a differential diagnosis, and ongoing monitoring are essential. The DEA's stance on initial in-person exams for Schedule II stimulants remains a key consideration, and practitioners should proceed cautiously, ensuring they meet all federal and state requirements for establishing a legitimate medical purpose.

Rhode Island has a progressive approach to the scope of practice for advanced practice registered nurses (APRNs) and physician assistants (PAs), reflecting a commitment to expanding access to care. Other mid-level providers and medical assistants also have defined roles.

Nurse Practitioners (NPs) / Advanced Practice Registered Nurses (APRNs): Rhode Island grants full practice authority to qualified APRNs. This means that APRNs, including Nurse Practitioners, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists, are authorized to practice independently without the direct supervision or collaborative practice agreement of a physician, provided they meet specific educational and certification requirements.

• Legal Basis: R.I. Gen. Laws § 5-34-34 specifies the scope of practice for APRNs, including the authority to diagnose, treat, prescribe (including controlled substances), and manage patient care. The Board of Nurse Registration and Nursing Education (BNRNE) promulgates regulations further defining this authority.
• Prescribing Authority: APRNs in Rhode Island have independent prescribing authority, including for Schedule II-V controlled substances, provided they hold a valid DEA registration and comply with all state and federal prescribing laws, including PDMP checks.
• Collaborative Practice Agreements: These are generally not required for APRNs in Rhode Island for independent practice. However, an APRN may choose to enter into a collaborative agreement for specific clinical situations or for professional development, but it is not a legal mandate for full practice authority.

Physician Assistants (PAs): Rhode Island PAs practice under a supervision agreement with a licensed physician, though the level of supervision has become more flexible.

• Legal Basis: R.I. Gen. Laws § 5-54-1 et seq. governs the practice of PAs. PAs are authorized to perform medical services delegated by their supervising physician, which includes diagnosing, treating, and prescribing.
• Supervision Requirements: While a supervision agreement is required, the current trend is towards 'physician-led team-based care' rather than direct, constant physician presence. The supervising physician is ultimately responsible for the PA's actions, but the supervision can be indirect, involving regular review of cases, chart review, and availability for consultation. The specific terms of supervision are outlined in a written supervision agreement filed with the Board of Medical Licensure and Discipline.
• Prescribing Authority: PAs in Rhode Island can prescribe medications, including controlled substances (Schedules II-V), within the scope of their supervision agreement and their training, provided they have a valid DEA registration and comply with all state and federal prescribing laws, including PDMP checks.

Other Mid-Level Providers (e.g., Physical Therapists, Optometrists): Each profession has its own specific scope of practice defined by statute and regulation. For example, Physical Therapists in Rhode Island have direct access, meaning patients can seek PT services without a physician referral, though certain conditions may require physician consultation. Optometrists have a broad scope, including the ability to prescribe certain therapeutic agents.

Delegation Rules for Medical Assistants (MAs) in Medspas: Medical Assistants (MAs) in Rhode Island operate under the direct supervision of a licensed physician, PA, or APRN. Their scope of practice is generally limited to administrative and clinical tasks that do not require independent medical judgment.

• Medspas: In medspas, MAs can perform tasks like taking vital signs, preparing patients for procedures, and assisting the licensed practitioner. However, they cannot independently perform procedures that constitute the practice of medicine, such as administering injectables (e.g., Botox, dermal fillers), performing laser treatments, or making clinical assessments. These procedures must be performed by a licensed physician, PA, or APRN, or delegated to a licensed nurse (RN, LPN) within their scope of practice, under appropriate supervision. Delegation of tasks to MAs must be within the MA's training and competence and must not involve independent decision-making or assessment. The supervising practitioner is fully responsible for the MA's delegated tasks.

Navigating business structuring in Rhode Island requires careful consideration of the Corporate Practice of Medicine (CPOM) doctrine, fee-splitting prohibitions, and professional licensing requirements. The goal is to ensure compliance while enabling efficient operations for healthcare companies.

PC-MSO Structures – When are they needed?

• Necessity: The Professional Corporation (PC) – Management Services Organization (MSO) model is frequently employed in Rhode Island to comply with CPOM regulations, particularly for lay-owned entities (e.g., private equity, technology companies) seeking to enter the healthcare market or for multi-state telehealth platforms. It is essential when non-licensed individuals or entities wish to own the administrative and non-clinical assets of a healthcare business, while licensed professionals maintain ownership and control over the clinical practice.
• Structure:
  • Professional Corporation (PC) or Professional Limited Liability Company (PLLC): This entity is owned by licensed healthcare professionals (e.g., physicians, dentists, APRNs). It holds the professional licenses, employs or contracts with the clinical staff, and delivers all medical services. This entity is responsible for all clinical decisions and patient care.
  • Management Services Organization (MSO): This is a separate, typically lay-owned, entity. It provides non-clinical administrative and management services to the PC/PLLC through a Management Services Agreement (MSA). Services can include billing, scheduling, marketing, IT support, facilities management, equipment leasing, and non-clinical human resources.

Fee-Splitting Rules: Rhode Island has prohibitions against fee-splitting, which generally means a licensed professional cannot share fees with an unlicensed person or entity for professional services rendered. R.I. Gen. Laws § 5-37-16(11) lists 'fee splitting' as unprofessional conduct for physicians. This is a critical consideration for MSO arrangements.

• MSA and Fee Structure: The compensation structure in an MSA must be carefully crafted to avoid fee-splitting. The MSO's fees to the PC/PLLC should be for legitimate, market-rate administrative services, not a percentage of the PC/PLLC's professional fees. Fees should ideally be fixed, cost-plus, or based on fair market value for the services provided, regardless of the volume or value of referrals or professional services rendered by the PC/PLLC. Any arrangement where the MSO's compensation is directly tied to a percentage of the professional fees could be deemed illegal fee-splitting.

Management Services Agreement (MSA) Requirements:

• Independence: The MSA must clearly delineate the roles and responsibilities, ensuring the PC/PLLC retains complete control over all clinical decisions, hiring/firing of clinical staff, and patient care. The MSO cannot interfere with the professional judgment of the licensed providers.
• Fair Market Value: All services provided by the MSO and the fees charged to the PC/PLLC must be at fair market value (FMV) and commercially reasonable. This is crucial for avoiding fee-splitting allegations and potential violations of anti-kickback statutes.
• Term and Termination: The MSA should have a defined term and clear termination clauses. It should not be perpetual or create an undue burden on the PC/PLLC.
• Compliance: The MSA should include provisions requiring both parties to comply with all applicable federal and state laws, including HIPAA, Stark Law (if applicable), and anti-kickback statutes.

Professional Corporation (PC) Requirements:

• Formation: Professional corporations are formed under R.I. Gen. Laws § 7-5.1-1 et seq. (Professional Service Corporations).
• Ownership: All shareholders of a PC must be licensed professionals authorized to render the specific professional service for which the corporation is organized. For medical PCs, all shareholders must be physicians. For dental PCs, all shareholders must be dentists.
• Name: The corporate name must include words like 'Professional Corporation' or 'P.C.'
• Purpose: The PC's sole purpose must be to render the specific professional services for which its shareholders are licensed.

How to Structure Ownership for Compliance:

• Direct Professional Ownership: For smaller practices or those solely owned by licensed professionals, a PC or PLLC directly owned by the practitioners is the simplest and most compliant structure.
• MSO Model: For lay investors or larger, multi-state operations, the PC-MSO model is the preferred compliant structure. The MSO owns the non-clinical assets and provides administrative services, while the PC/PLLC owns the clinical assets and delivers patient care. Clear contractual separation and adherence to FMV for MSO services are paramount.
• Avoid Indirect Control: Any structure that gives a non-licensed entity indirect control over clinical decision-making or allows them to profit directly from the provision of professional medical services will likely violate Rhode Island's CPOM and fee-splitting prohibitions. This includes arrangements where the MSO dictates clinical protocols, controls physician compensation based on patient volume, or has undue influence over hiring/firing of clinical staff.

Rhode Island continues to be an active legislative and regulatory environment for healthcare, with several key developments and ongoing trends impacting telehealth, CPOM, and prescribing practices.

Telehealth Legislation and Regulations:

• Permanent Telehealth Parity (2021-2022): Following the COVID-19 Public Health Emergency (PHE), Rhode Island codified many emergency telehealth flexibilities into permanent law. R.I. Gen. Laws § 27-20-1.1, enacted through various legislative efforts, established permanent reimbursement parity for telehealth services (meaning insurers must reimburse telehealth services at the same rate as in-person services, subject to certain conditions), expanded the definition of telehealth to include audio-only, and clarified informed consent requirements. This legislative action solidified Rhode Island's commitment to telehealth access.
• Behavioral Health Focus: Recent legislative sessions have seen an increased focus on expanding access to behavioral health services via telehealth. Bills have been introduced and passed to ensure continued coverage and access, recognizing the critical role telehealth plays in this area. For example, the 2023 legislative session continued to reinforce these protections.

Corporate Practice of Medicine (CPOM) Enforcement:

• Continued Vigilance: While there haven't been major legislative overhauls of CPOM, the Board of Medical Licensure and Discipline (BMLD) remains vigilant. Enforcement actions, though not always widely publicized, typically stem from complaints related to unlicensed practice, fee-splitting, or situations where lay entities exert undue influence over clinical decisions. Companies should assume that any structure perceived to compromise physician independence will draw scrutiny.
• Medspa Regulations: The proliferation of medspas has led to increased attention from the BMLD and the Department of Health regarding appropriate supervision, delegation of tasks, and ownership structures. While not a new law, the enforcement of existing CPOM principles in this sector is a continuing trend.

Prescribing Rules and Controlled Substances:

• Opioid Prescribing Updates: Rhode Island continues to refine its opioid prescribing laws. While the initial 7-day limit for acute pain remains, there are ongoing discussions and minor adjustments to exceptions and reporting requirements to balance pain management with addiction prevention. Practitioners should regularly check RIDOH and BMLD guidance.
• PDMP Enhancements: The state's Prescription Drug Monitoring Program (PDMP) is continually enhanced, with efforts to improve interoperability and user experience. Compliance with mandatory PDMP checks remains a high priority for regulators.
• Federal DEA Rules: The biggest 'pending legislation' impact on controlled substance prescribing via telehealth comes from the federal level. The DEA's proposed rules for post-PHE prescribing of controlled substances via telehealth (which could reintroduce an in-person exam requirement for certain substances) are critical. Rhode Island practitioners must monitor these federal developments closely, as they will directly impact state practice.

Interstate Compact Participation:

• Interstate Medical Licensure Compact (IMLC): Rhode Island is a member of the IMLC, which facilitates expedited licensure for eligible physicians. This significantly streamlines the process for physicians seeking to practice in multiple compact states, including providing telehealth services to Rhode Island residents.
• Nurse Licensure Compact (NLC): Rhode Island is also a member of the NLC, allowing eligible registered nurses (RNs) and licensed practical nurses (LPNs) to hold a multi-state license and practice in other compact states without obtaining additional licenses. This greatly benefits telehealth nursing services.

Entering the Rhode Island healthcare market requires a structured approach to ensure compliance from the outset. Here's actionable guidance for healthcare companies.

Step-by-Step Compliance Checklist:

1. Entity Formation:
   • Clinical Entity: Form a Rhode Island Professional Corporation (PC) or Professional Limited Liability Company (PLLC) for the clinical practice. Ensure its ownership is solely by licensed professionals (e.g., physicians, dentists, APRNs) in the respective field. Register with the RI Secretary of State.
   • Administrative Entity (if MSO Model): Form a separate, lay-owned LLC or corporation for the Management Services Organization (MSO) to handle non-clinical functions. Register with the RI Secretary of State.
2. Licensure:
   • Provider Licensing: Ensure all healthcare professionals (physicians, NPs, PAs, dentists, etc.) are fully licensed by their respective Rhode Island professional boards (e.g., Board of Medical Licensure and Discipline, Board of Nurse Registration and Nursing Education). Leverage compacts (IMLC, NLC) where applicable for expedited licensure.
   • DEA Registration: Any provider prescribing controlled substances must have an active Rhode Island-specific DEA registration.
3. Contractual Agreements:
   • Management Services Agreement (MSA): Draft a robust MSA between the MSO and the PC/PLLC. Ensure it clearly defines services, compensation (FMV, not percentage-based), and explicitly states the PC/PLLC retains full clinical control. Have it reviewed by Rhode Island healthcare counsel.
   • Employment/Independent Contractor Agreements: Ensure all agreements with clinical staff (physicians, NPs, PAs) are compliant with state labor laws and clearly define their roles and responsibilities within the PC/PLLC.
4. Telehealth Protocols:
   • Informed Consent: Implement a clear process for obtaining and documenting informed consent for telehealth services, as required by R.I. Gen. Laws § 27-20-1.1(b)(3).
   • Standard of Care: Establish protocols ensuring that telehealth services meet the same standard of care as in-person services.
   • Modality Use: Define when specific modalities (video, audio-only, asynchronous) are appropriate based on clinical need and state law.
5. Prescribing Compliance:
   • PDMP: Integrate mandatory Rhode Island PDMP checks into prescribing workflows for opioids and benzodiazepines.
   • Controlled Substances: Develop strict protocols for controlled substance prescribing via telehealth, adhering to both state limits (e.g., opioid quantity) and federal DEA requirements (monitor post-PHE rules closely).
6. Privacy and Security: Implement HIPAA-compliant policies and procedures for all patient data, especially with telehealth technology.

Common Pitfalls to Avoid:

• Ignoring CPOM: Assuming Rhode Island has no CPOM or attempting to circumvent it with poorly structured MSO agreements. Direct lay ownership of medical practices is a significant risk.
• Improper Fee-Splitting: Structuring MSO fees as a percentage of professional revenue, which can be construed as illegal fee-splitting.
• Inadequate Licensure: Operating with providers not fully licensed in Rhode Island, or relying solely on out-of-state licenses without compact eligibility.
• Lack of Informed Consent: Failing to obtain and document proper informed consent for telehealth services.
• Non-Compliance with PDMP: Overlooking mandatory PDMP checks for controlled substances.
• Interference with Clinical Judgment: Allowing the MSO or non-clinical staff to influence or dictate clinical decisions of licensed providers.

Timeline Expectations for Licensing and Setup:

• Entity Formation (Secretary of State): 1-3 weeks.
• Professional Licensing (e.g., Medical Board):
  • IMLC/NLC: 2-4 weeks for expedited licenses (after compact eligibility is confirmed).
  • Full RI Licensure: 2-4 months, depending on board meeting schedules, application completeness, and background check processing. Start this process early.
• DEA Registration: 2-4 weeks after state licensure.
• MSA and Other Contracts: 4-8 weeks (drafting, review by counsel, negotiation).
• System Setup & Credentialing: Varies widely, but allow 2-6 months for full operational readiness, including payer credentialing if accepting insurance.

Proactive engagement with experienced Rhode Island healthcare counsel is essential to navigate these complexities and ensure a compliant market entry.